Business
Pediatric drugs expected to see healthy sales growth
NEWS IN BRIEF — Posted Jan. 30, 2006
Sales of pediatric prescription drugs are expected to grow more than 6% annually and exceed a total of $46 billion by 2009, according to a report by Kalorama Information, a division of the life science researcher MarketResearch.com.
Experts point to the high number of children in Asia, Africa and Latin America as their reason why the pediatric prescription drug industry will continue to grow. The market was expected to see sales of about $36.4 billion in 2005, according to the report.
Allergy gastrointestinal drugs were expected to lead the growth of the overall industry, according to the report.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2006/01/30/bibf0130.htm.